ViaDerma, Inc.
ViaDerma, Inc. (VDRM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
vdrm · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
ViaDerma, Inc.You VDRM | $0M | N/A | — | — |
 Aoxing Pharmaceutical Company, Inc. AOXG | $0M | 51.76x | — | $0.00 |
 Plant-Based Investment Corp. CWWBF | $0M | N/A | — | -$0.23 |
 4Front Ventures Corp. FFNTF | $0M | N/A | — | -$0.14 |
 Grapefruit USA, Inc. GPFT | $1M | N/A | — | -$0.00 |
 GelStat Corporation GSAC | $0M | N/A | — | -$0.00 |
 Link Reservations Inc. LRSV | $0M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for ViaDerma, Inc. (VDRM) measures how much investors pay for each dollar of the company's trailing earnings. VDRM's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of —.
Frequently asked questions
VDRM pe ratio · 6 questionsVDRM's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of —. Data sourced from Financial Modeling Prep via VDRM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ViaDerma, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09